KAYACAN, O. Et Al. 2006. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.29, no.4 , 328-335.

KAYACAN, O., Karnak, D., Beder, S., Gullu, E., Tutkak, H., Senler, F., ... KÖKSAL, D.(2006). Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.29, no.4, 328-335.

KAYACAN, OYA Et Al. "Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.29, no.4, 328-335, 2006

KAYACAN, OYA Et Al. "Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.29, no.4, pp.328-335, 2006

KAYACAN, O. Et Al. (2006) . "Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.29, no.4, pp.328-335.

@article{article, author={OYA KAYACAN Et Al. }, title={Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2006, pages={328-335} }